Abstract:AimTo explore the diagnostic models of Crohn's disease (CD), Intestinal tuberculosis (ITB) and the differential diagnostic model between CD and ITB by analyzing serum proteome profiles.MethodsSerum proteome profiles from 30 CD patients, 21 ITB patients and 30 healthy controls (HCs) were analyzed by using weak cationic magnetic beads combined with MALDI-TOF-MS technique to detect the differentially expressed proteins of serum samples. Three groups were made and compared accordingly: group of CD patients and HCs, group of ITB patients and HCs, group of CD patients and ITB patients. Wilcoxon rank sum test was used to screen the ten most differentiated protein peaks (P < 0.05). Genetic algorithm combining with support vector machine (SVM) was utilized to establish the optimal diagnostic models for CD, ITB and the optimal differential diagnostic model between CD and ITB. The predictive effects of these models were evaluated by Leave one out (LOO) cross validation method.ResultsThere were 236 protein peaks differently expressed between group of CD patients and HCs, 305 protein peaks differently expressed between group of ITB patients and HCs, 332 protein peaks differently expressed between group of CD patients and ITB patients. Ten most differentially expressed peaks were screened out between three groups respectively (P < 0.05) to establish diagnostic models and differential diagnostic model. A diagnostic model comprising of four protein peaks (M/Z 4964, 3029, 2833, 2900) can well distinguish CD patients and HCs, with a specificity and sensitivity of 96.7% and 96.7% respectively. A diagnostic model comprising four protein peaks (M/Z 3030, 2105, 2545, 4210) can well distinguish ITB patients and HCs, with a specificity and sensitivity of 93.3% and 95.2% respectively. A differential diagnostic model comprising three potential biomarkers protein peaks (M/Z 4267, 4223, 1541) can well distinguish CD patients and ITB patients, with a specificity and sensitivity of 76.2% and 80.0% respectively. Among the eleven protein peaks from the diagnostic models and differential diagnostic model, two have been successfully purified and identified, Those two peaks were M/Z 2900 from the diagnostic model between CD and HCs and M/Z 1541 from the differential diagnostic model between CD and ITB. M/Z 2900 was identified as appetite peptide, M/Z 1541 was identified as Lysyl oxidase-like 2 (LOXL-2).ConclusionThe differently expressed protein peaks analyzed by serum proteome with weak cationic magnetic beads combined MALDI-TOF-MS technique can effectively distinguish CD patients and HCs, ITB patients and HCs, CD patients and ITB patients. The diagnostic model between CD patients and HCs consisting of four protein peaks (M/Z 4964, 3029, 2833, 2900), the diagnostic model between ITB patients and HCs comprising four protein peaks (M/Z 3030, 2105, 2545, 4210) and the differential diagnostic model between CD patients and ITB patients comprising three protein peaks (M/Z 4267, 4223, 1541) had high specificity and sensitivity and can contribute to diagnoses of CD, ITB and the differential diagnosis between CD and ITB. Two proteins from the diagnostic model of CD and the differential diagnostic model between CD and ITB were identified. Further experiments are required using a larger cohort of samples.

Clinical and Endoscopic Analysis of Crohn's Disease and Intestinal Tuberculosis

Clinical Features, Differential Diagnosis and Intestinal Mucosal TB-PCR for Intestinal Tuberculosis and Crohn's Disease

Differential Diagnosis Between Crohn's Disease and Intestinal Tuberculosis Based on Clinical Manifestations, Endoscopic and CT Findings

Differential Diagnosis Between Crohn's Disease and Intestinal Tuberculosis in China

Clinical and Colonoscopic Characteristics of Crohn Disease and Intestinal Tuberculosis

Differentiation Of Crohn'S Disease From Intestinal Tuberculosis By Clinical And Ct Enterographic Models

A Comparison of Clinical and Pathologic Characteristics Between Crohn's Disease and Intestinal Tuberculosis

Differentiating Crohnʼs Disease from Intestinal Tuberculosis Using an Interferon Gamma Release Assay

Differential Diagnosis Between Crohn's Disease, Intestinal Tuberculosis and Primary Small Intestinal Lymphoma Based on Clinical Features, Endoscopic and CT Fingings

Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis

The value of CTE in differential diagnosis of Crohn' s disease and intestinal tuberculosis

Clinical Analysis of Intestinal Tuberculosis: A Retrospective Study

CHnical and Endoscopic Evaluation of Anti-Tuberculosis Trial for Differentiation Between Intestinal Tuberculosis and Crohn＇s Disease

Differences in clinical features of Crohn's disease and intestinal tuberculosis.

[Characteristics and Differential Diagnosis of Intestinal Flora in Crohn's Disease and Intestinal Tuberculosis].

Serum proteome profiles to differentiate Crohn disease from intestinal tuberculosis and primary intestinal lymphoma: A pilot study.

Granulomas As The Most Useful Histopathological Feature In Distinguishing Between Crohn'S Disease And Intestinal Tuberculosis In Endoscopic Biopsy Specimens

The value of empiric anti-tuberculosis therapy in the differential diagnosis between intestinal tuberculosis and Crohn ’ s disease in China

[Differential Diagnosis of Intestinal Tuberculosis and Primary Small Intestinal Lymphoma Using Endoscopy and Computerized Tomography].

Value of Polymerase Chain Reaction for Mycobacterium Tuberculosis Differential Diagnosis of Intestinal Tuberculosis and Crohn's Disease

Confluent granulomas and ulcers lined by epithelioid histiocytes: new ideal method for differentiation of ITB and CD? A meta analysis.